Subtype
Liver Carcinoma
CI-CAN-00001073Explore in graph →
783 active trials14 approved drugs17 evidence items
- NCIt
- C7927
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001073Explore in graph →
Clinical trials
3,367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (386)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | unknown | Phase 2 | 28 | Sun Yat-sen UniversityOTHER | 1 | Apr 27, 2015 | clinicaltrials |
| NCT01492127 | Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment | unknown | N/A | 64 | University Hospital, MontpellierOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT02418988 | Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT02399033 | Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy | unknown | Phase 4 | 1,000 | Shuqun ChengOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT02327819 | The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer | unknown | N/A | 60 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02290977 | Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT02308319 | Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load(POWER) | unknown | Phase 4 | 124 | Samsung Medical CenterOTHER | 0 | Dec 4, 2014 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT02242786 | Diffusion-Weighted Magnetic Resonance Imaging | unknown | Phase 2 | 17 | Samsung Medical CenterOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT02253511 | A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma | unknown | Phase 4 | 400 | Zheng DonghaiOTHER_GOV | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02240771 | Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | 124 | All India Institute of Medical SciencesOTHER | 1 | Sep 16, 2014 | clinicaltrials |
| NCT02238613 | Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer | unknown | N/A | 140 | 307 Hospital of PLAOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT02238769 | 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma | unknown | — | 80 | Peking Union Medical College HospitalOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT02184871 | Next Generation Sequencing in Intrahepatic Cholangiocarcinoma(EtherBil) | unknown | — | 45 | University of BolognaOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT01721941 | TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 20 | Scripps Clinic Cancer CenterOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT02018757 | Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC(SEATH) | unknown | Phase 2 | 250 | First Hospital of China Medical UniversityOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT02148562 | Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity | unknown | — | 274 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT02131441 | Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection | unknown | N/A | 2 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01957241 | PLA for HCC and Esophageal ca Serum | unknown | — | 164 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01272557 | Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial(SoraDox) | unknown | Phase 2 | 170 | PD Dr. med. Matthias DollingerOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT02074202 | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | unknown | Phase 3 | 150 | National Taiwan University HospitalOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT02070822 | 3T MRI to Predict TACE Response of HCC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02051283 | Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT02036216 | Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 2 | Jan 14, 2014 | clinicaltrials |
| NCT01997957 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC(SOON) | unknown | Phase 4 | 110 | Zhu XuOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01930383 | Circulating Tumor Cells for Hepatocellular Carcinoma(CTCs for HCC) | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01957618 | The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy(CTEAM) | unknown | — | 1,500 | National Taiwan University HospitalOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01924624 | Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT01917370 | VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway(icc) | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 6, 2013 | clinicaltrials |
| NCT01894269 | Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Jul 23, 2013 | clinicaltrials |
| NCT01892072 | VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway(HCC) | unknown | — | 50 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's HospitalOTHER | 0 | Jun 5, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01833286 | TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01668381 | Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT01764438 | Utility Study of Primovist-MRI on HCC Staging(PrimovistMRI) | unknown | — | 174 | Inha University HospitalOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01575717 | The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List | unknown | N/A | 50 | Andrea BranchOTHER | 1 | Oct 24, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01677468 | Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma | unknown | N/A | 250 | Hallym University Medical CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438437 | Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis | unknown | Phase 4 | 54 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01607788 | Prospective Liver Tumor (ProLiT) Database(ProLit) | unknown | — | 500 | University of Geneva, SwitzerlandOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT01605734 | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 25, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Apr 27, 2015source: clinicaltrials